Jose Luis Marin-Teva

Jose Luis Marin-Teva

Auto-generated profile, based on publicly available information

Jose Luis Marin-Teva

Departamento de Biología Celular, Facultad de Ciencias, Universidad de Granada, Granada, Spain

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2011 in Neuron Glia Biology
Verified
Journal Article
Closed access
JMJosé L. Marín-Teva
José L. Marín-Teva
MCMiguel A. Cuadros
Miguel A. Cuadros
DMDavid Martín-Oliva
David Martín-Oliva
JNJulio Navascués
Julio Navascués
Microglia, the brain's innate immune cell type, are cells of mesodermal origin that populate the central nervous system (CNS) during development. Undifferentiated microglia, also called ameboid microglia, have the ability to proliferate, phagocytose apoptotic cells and migrate long distances toward their final destinations throughout all CNS regions, where they acquire a mature ramified morphological phenotype. Recent studies indicate that ameboid microglial cells not only have a scavenger role during development but can also promote the death of some neuronal populations. In the mature CNS, adult microglia have highly motile processes to scan their territorial domains, and they display a panoply of effects on neurons that range from sustaining their survival and differentiation contributing to their elimination. Hence, the fine tuning of these effects results in protection of the nervous tissue, whereas perturbations in the microglial response, such as the exacerbation of microglial activation or lack of microglial response, generate adverse situations for the organization and function of the CNS. This review discusses some aspects of the relationship between microglial cells and neuronal death/survival both during normal development and during the response to injury in adulthood.

29 August 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ASAna Sierra
Ana Sierra
JNJulio Navascués
Julio Navascués
MCMiguel A. Cuadros
Miguel A. Cuadros
RCRuth Calvente
Ruth Calvente
DMDavid Martín-Oliva
David Martín-Oliva
JMJosé L. Marín-Teva
José L. Marín-Teva
Inducible nitric oxide synthase (iNOS), which produce large amounts of nitric oxide (NO), is induced in macrophages and microglia in response to inflammatory mediators such as LPS and cytokines. Although iNOS is mainly expressed by microglia that become activated in different pathological and experimental situations, it was recently reported that undifferentiated amoeboid microglia can also express iNOS during normal development. The aim of this study was to investigate the pattern of iNOS expression in microglial cells during normal development and after their activation with LPS by using the quail retina as model. iNOS expression was analyzed by iNOS immunolabeling, western-blot, and RT-PCR. NO production was determined by using DAR-4M AM, a reliable fluorescent indicator of subcellular NO production by iNOS. Embryonic, postnatal, and adult in situ quail retinas were used to analyze the pattern of iNOS expression in microglial cells during normal development. iNOS expression and NO production in LPS-treated microglial cells were investigated by an in vitro approach based on organotypic cultures of E8 retinas, in which microglial cell behavior is similar to that of the in situ retina, as previously demonstrated in our laboratory. We show here that amoeboid microglia in the quail retina express iNOS during normal development. This expression is stronger in microglial cells migrating tangentially in the vitreal part of the retina and is downregulated, albeit maintained, when microglia differentiate and become ramified. LPS treatment of retina explants also induces changes in the morphology of amoeboid microglia compatible with their activation, increasing their lysosomal compartment and upregulating iNOS expression with a concomitant production of NO. Taken together, our findings demonstrate that immature microglial cells express iNOS during normal development, suggesting a certain degree of activation. Furthermore, LPS treatment induces overactivation of amoeboid microglia, resulting in a significant iNOS upregulation.

20 August 1999 in Glia
Verified
Journal Article
Open access
PDF file
RCRuth Calvente
Ruth Calvente
MCMiguel A. Cuadros
Miguel A. Cuadros
AAAntonio Almendros
Antonio Almendros
JMJosé L. Marín‐Teva
José L. Marín‐Teva
JNJulio Navascués
Julio Navascués
Central‐to‐peripheral migration of QH1‐positive microglial precursors occurs in the vitrealmost part of the developing quail retina. This study shows that some QH1‐positive ameboid cells with morphological features of migrating cells are already present in the margin of the retina before microglial precursors migrating centrally to peripherally arrive in this zone. Because the earlier cells are oriented parallel to the ora serrata, we deduce that some microglial cells migrate circumferentially in the margin of the retina, whereas other microglial precursors migrate from central to peripheral zones. Microglial cells that migrate circumferentially are first seen on embryonic day 6 (E6) and advance in a temporal‐to‐dorsal‐to‐nasal direction from the temporoventral quadrant of the retina. When cells migrating centrally to peripherally reach the retinal margin, they meet those migrating circumferentially. From E6 on, some QH1‐positive dendritic cells in the ciliary body bear processes that penetrate the retina, where they are oriented circumferentially. These observations suggest that microglial cells that migrate circumferentially in the retinal margin share a common origin with dendritic cells of the ciliary body. Therefore, microglial cells of the quail retina appear to make up a heterogeneous population, with some cells originating from the pecten/optic nerve head area and others from the ciliary body. GLIA 27:226–238, 1999.

1 August 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MEMaría Martín Estebané
María Martín Estebané
JNJulio Navascués
Julio Navascués
ASAna Sierra-Martín
Ana Sierra-Martín
SGSandra Maria Martin Guerrero
Sandra Maria Martin Guerrero
MCMiguel A. Cuadros
Miguel A. Cuadros
JMJosé L Marín-Teva
José L Marín-Teva
Microglial cell precursors located in the area of the base of the pecten and the optic nerve head (BP/ONH) start to enter the retina of quail embryos at the 7th day of incubation (E7), subsequently colonizing the entire retina by central-to-peripheral tangential migration, as previously shown by our group. The present study demonstrates a precise chronological coincidence of the onset of microglial cell entry into the retina with a striking increase in death of retinal cells, as revealed by their active caspase-3 expression and TUNEL staining, in regions dorsal to the BP/ONH area, suggesting that dying retinal cells would contribute to the microglial cell inflow into the retina. However, the molecular mechanisms involved in this inflow are currently unclear. Extracellular nucleotides, such as ATP and UDP, have previously been shown to favor migration of microglia towards brain injuries because they are released by apoptotic cells and stimulate both chemotaxis and chemokinesis in microglial cells via signaling through purinergic receptors. Hence, we tested here the hypothesis that ATP and UDP play a role in the entry and migration of microglial precursors into the developing retina. For this purpose, we used an experimental model system based on organotypic cultures of E6.5 quail embryo retina explants, which mimics the entry and migration of microglial precursors in the in situ developing retina. Inhibition of purinergic signaling by treating retina explants with either apyrase, a nucleotide-hydrolyzing enzyme, or suramin, a broad spectrum antagonist of purinergic receptors, significantly prevents the entry of microglial cells into the retina. In addition, treatment of retina explants with either exogenous ATP or UDP results in significantly increased numbers of microglial cells entering the retina. In light of these findings, we conclude that purinergic signaling by extracellular ATP and UDP is necessary for the entry and migration of microglial cells into the embryonic retina by inducing chemokinesis in these cells.

27 January 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
Ana Isabel Sánchez-CastilloAna Isabel Sánchez-Castillo
Ana Isabel Sánchez-Castillo
MSM. Rosario Sepulveda
M. Rosario Sepulveda
JMJosé Luis Marín-Teva
José Luis Marín-Teva
MCMiguel A. Cuadros
Miguel A. Cuadros
DMDavid Martín-Oliva
David Martín-Oliva
VNVeronika E. Neubrand
Veronika E. Neubrand
Neurological disorders, including neurodegenerative diseases, are often characterized by neuroinflammation, which is largely driven by microglia, the resident immune cells of the central nervous system (CNS). Under these conditions, microglia are able to secrete neurotoxic substances, provoking neuronal cell death. However, microglia in the healthy brain carry out CNS-supporting functions. This is due to the ability of microglia to acquire different phenotypes that can play a neuroprotective role under physiological conditions or a pro-inflammatory, damaging one during disease. Therefore, therapeutic strategies focus on the downregulation of these neuroinflammatory processes and try to re-activate the neuroprotective features of microglia. Mesenchymal stem cells (MSC) of different origins have been shown to exert such effects, due to their immunomodulatory properties. In recent years, MSC derived from adipose tissue have been made the center of attention because of their easy availability and extraction methods. These cells induce a neuroprotective phenotype in microglia and downregulate neuroinflammation, resulting in an improvement of clinical symptoms in a variety of animal models for neurological pathologies, e.g., Alzheimer’s disease, traumatic brain injury and ischemic stroke. In this review, we will discuss the application of adipose tissue-derived MSC and their conditioned medium, including extracellular vesicles, in neurological disorders, their beneficial effect on microglia and the signaling pathways involved.

30 November 2010 in Developmental Neurobiology
Verified
Journal Article
Closed access
PDF file
MCMaria‐Carmen Carrasco
Maria‐Carmen Carrasco
JNJulio Navascués
Julio Navascués
MCMiguel A. Cuadros
Miguel A. Cuadros
RCRuth Calvente
Ruth Calvente
DMDavid Martín‐Oliva
David Martín‐Oliva
JMJosé L. Marín‐Teva
José L. Marín‐Teva